In this context, recent studies have yielded encouraging results from the use of glucose sensors in combination with an insulin pump18, which suggests that glucose variability could be an important measure for validating new DM therapies, as well as for predicting the risk of DM and its vascular complications. The gene discussed is INS; the disease is diabetes mellitus.